Cover Image for Info and Q&A Session: T2B Leadership Lab
Cover Image for Info and Q&A Session: T2B Leadership Lab
Private Event

Info and Q&A Session: T2B Leadership Lab

Hosted by Ticket to Biotech
Zoom
Registration
Approval Required
Your registration is subject to approval by the host.
Welcome! To join the event, please register below.
About Event

Join us for this informal informational and Q&A session with executive coach and Leadership Lab facilitator Carly Goldsmith.

Say hi to Carly, find out what to expect, and get your questions answered about T2B's first premium offering, open exclusively to seasoned biopharma communicators.


DECIDING WHETHER NOW IS THE RIGHT TIME TO INVEST IN TAILORED EXECUTIVE COACHING?

The Corporate Advisor Series is designed to elevate the influence of communications leaders in highly regulated environments like ours, aligning directly with both our functional and corporate objectives. You’ll have the opportunity for tailored executive coaching as well as interactive sessions that provide practical skills. By participating, you'll further develop your ability to lead business initiatives, manage complex stakeholder relationships, and drive strategic decisions effectively.

MEET CARLY

Carly Goldsmith is a Professional Certified Coach (PCC) with over 20 years of experience coaching high-potential senior and emerging leaders and their teams. She is a versatile and trusted partner who supports leaders to create real impact and sustainable results through improvements in their effectiveness, cohesion, and performance. Compassionate and intuitive by nature, Carly’s style is often described as engaging, insightful, and empowering.

Carly has coached leaders across multiple industries throughout the US and globally. In addition to her coaching, she has designed and facilitated in-person and virtual workshops, leadership development programs and team coaching engagements. Recent clients include Deloitte, Amazon, Charles River Associates, Verve, ImmunoGen/AbbVie, Teradata, Alnylam, Dragonfly, Broad Institute, Mass General Brigham, Dana Farber, Alexion, Morgan Stanley, SCAN Foundation, and Needham Bank.